Home News Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth... News Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth despite labour code cost February 9, 2026 FacebookTwitterPinterestWhatsAppLinkedin Shares of Aurobindo Pharma Ltd ended at ₹1,201.25, up by ₹10.10, or 0.85%, on the BSE.Read More RELATED ARTICLESMORE FROM AUTHOR News Goyal urges industry to raise quality standards to achieve $2 trillion export target News PM Narendra Modi to inaugurate Noida International Airport in March, says Yogi Adityanath AI AI startup Emergent scales at record speed by letting anyone build apps on their phone 13,000FansLike9,000FollowersFollowMost PopularAll AllFeaturedAll time popular Tata Electronics’ Upcoming Fab To Enable Prototype Chip Production For Indian... Uncategorized January 27, 2026 Marico’s Cosmix Deal, Whole Truth’s $51 Mn Round & More Uncategorized February 5, 2026 Texmaco Rail lands ₹219 crore Mumbai suburban rail contract News February 16, 2026 Boeing to Reduce Defence Supply Chain Workforce in Cost-Cutting Drive Uncategorized February 5, 2026 Cognizant To Offer 100% Bonus To Eligible Employees Uncategorized February 6, 2026